Doctor profile · Federal record

Dr. Charles Delgiorno, MD

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Internal Medicine Physician · Sewell, NJ

  • NPI 1548455314
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 23 yrs in practice
  • Licensed in 2 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
239 Hurffville Crosskeys RD, Ste 370
Sewell, NJ 080804001
(856) 728-3636
fax (856) 728-3633
Mailing address
402 Lippincott Dr
Marlton, NJ 080534112

Credentials & registration

NPPES · NUCC
NPI registered
September 2007 — 19 yrs on file
Profile last updated
March 4, 2010
Year of graduation
2003 — 23 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State licenses (2)
New Jersey #25MA08562500 · Florida #ME99112
Medicaid (2)
FL #279722400 · NJ #0208680

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1548455314. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
1,635
Distinct HCPCS
7
Medicare allowed
$170,395
HCPCS Description Services Patients Avg allowed
99214 Established patient office or other outpatient visit, 30-39 minutes 989 470 $135
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 463 200 $36
99204 New patient office or other outpatient visit, 45-59 minutes 66 66 $175
83036 Hemoglobin a1c level 60 52 $10
99215 Established patient office or other outpatient visit, 40-54 minutes 33 31 $187
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report 13 12 $16
95250 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment 11 11 $163

In context: peer comparison

Among 3 peers in this city , average services per provider: 138. This provider delivers 12× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,412
Transactions
72
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novo Nordisk Inc 18 $340.92
Abbott Laboratories 15 $263.05
Insulet Corporation 6 $130.47
Lilly USA, LLC 6 $108.12
Tandem Diabetes Care, Inc. 4 $87.08
Amphastar Pharmaceuticals, Inc. 5 $74.37
Antares Pharma, Inc. 4 $67.72
IBSA Pharma Inc. 3 $47.42
Tolmar, Inc. 3 $40.85
Amgen Inc. 2 $32.68
Xeris Pharmaceuticals, Inc. 2 $32.05
Dexcom, Inc. 1 $23.82
Radius Health, Inc. 1 $22.51
Corcept Therapeutics 1 $21.51
Alexion Pharmaceuticals, Inc. 1 $18.68

By nature of payment

Food and Beverage
$1,412

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,463
Patients
860
Total drug cost
$1,095,781
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 488 139 $8,654
Metformin Hcl Generic 404 137 $5,492
Glipizide Generic 202 69 $3,512
Ozempic (Semaglutide) Brand 186 62 $371,447
Nano 2nd Gen Pen Needle (Pen Needle, Diabetic) Brand 157 70 $18,091
Trulicity (Dulaglutide) Brand 157 51 $348,013
Metformin Hcl Er (Metformin Hcl) Brand 155 51 $3,510
Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) Brand 133 66 $141,405
Methimazole Generic 118 33 $1,691
Novolog Flexpen (Insulin Aspart) Brand 100 47 $169,012

Frequently asked questions

Auto-generated from federal data
What is Dr. Charles Delgiorno's medical specialty?
Dr. Charles Delgiorno practices Endocrinology, Diabetes & Metabolism Physician in Sewell, NJ.
Where does Dr. Charles Delgiorno practice?
Dr. Charles Delgiorno practices at 239 Hurffville Crosskeys RD, Sewell, NJ 080804001. Office phone: 8567283636.
What is Dr. Charles Delgiorno's NPI?
Dr. Charles Delgiorno's National Provider Identifier (NPI) is 1548455314, issued by NPPES.
Does Dr. Charles Delgiorno accept Medicare assignment?
Yes. Dr. Charles Delgiorno accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Charles Delgiorno commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251); New patient office or other outpatient visit (HCPCS 99204). Source: CMS Medicare Physician & Other Practitioners file.